Natixis’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,456
| Closed | -$1.64M | – | 1153 |
|
|
2024
Q4 | $1.64M | Buy |
13,456
+3,337
| +33% | +$406K | 0.01% | 498 |
|
|
2024
Q3 | $1.26M | Buy |
10,119
+9,653
| +2,071% | +$1.21M | 0.01% | 484 |
|
|
2024
Q2 | $73.6K | Sell |
466
-129
| -22% | -$20.4K | ﹤0.01% | 747 |
|
|
2024
Q1 | $77K | Buy |
+595
| New | +$77K | ﹤0.01% | 779 |
|
|
2023
Q2 | – | Sell |
-1,750
| Closed | -$241K | – | 1126 |
|
|
2023
Q1 | $241K | Sell |
1,750
-105,550
| -98% | -$14.5M | ﹤0.01% | 715 |
|
|
2022
Q4 | $13.9M | Sell |
107,300
-30,250
| -22% | -$3.92M | 0.08% | 214 |
|
|
2022
Q3 | $15.2M | Sell |
137,550
-41,100
| -23% | -$4.54M | 0.07% | 206 |
|
|
2022
Q2 | $13.4M | Buy |
178,650
+43,750
| +32% | +$3.28M | 0.05% | 239 |
|
|
2022
Q1 | $10.5M | Sell |
134,900
-102,500
| -43% | -$8.01M | 0.04% | 409 |
|
|
2021
Q4 | $21.4M | Buy |
+237,400
| New | +$21.4M | 0.07% | 221 |
|
|
2021
Q2 | – | Sell |
-5,484
| Closed | -$409K | – | 1002 |
|
|
2021
Q1 | $409K | Sell |
5,484
-160,931
| -97% | -$12M | ﹤0.01% | 971 |
|
|
2020
Q4 | $28.4M | Buy |
+166,415
| New | +$28.4M | 0.1% | 199 |
|
|
2019
Q1 | – | Sell |
-39,805
| Closed | -$4.34M | – | 875 |
|
|
2018
Q4 | $4.34M | Buy |
39,805
+26,254
| +194% | +$2.87M | 0.04% | 346 |
|
|
2018
Q3 | $2.19M | Buy |
13,551
+9,197
| +211% | +$1.49M | 0.01% | 474 |
|
|
2018
Q2 | $576K | Sell |
4,354
-3,258
| -43% | -$431K | ﹤0.01% | 676 |
|
|
2018
Q1 | $564K | Sell |
7,612
-5,948
| -44% | -$441K | ﹤0.01% | 656 |
|
|
2017
Q4 | $754K | Buy |
+13,560
| New | +$754K | 0.01% | 540 |
|